Literature DB >> 14499061

Which questionnaires should be used in female urology practice?

Christopher E Kelly1.   

Abstract

The evaluation and treatment of female pelvic floor disorders is an evolving sub-specialty in urology. Recent attention has been directed toward more rigorous evaluation of treatment efficacy and durability of female urologic procedures. Throughout the past few decades, questionnaires have emerged as important subjective instruments for evaluation. Today, practitioners must choose from a burgeoning amount of questionnaires. This staggering number of questionnaires has raised two important issues: which questionnaire should be used in a female urology practice and should more refined criteria be developed for evaluating questionnaires to make the decision easier?

Entities:  

Mesh:

Year:  2003        PMID: 14499061     DOI: 10.1007/s11934-003-0011-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  51 in total

1.  Quality of life measurement: will we ever be satisfied?

Authors:  A E Bonomi; D L Patrick; D M Bushnell; M Martin
Journal:  J Clin Epidemiol       Date:  2000-01       Impact factor: 6.437

2.  Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. The American Urological Association.

Authors:  G E Leach; R R Dmochowski; R A Appell; J G Blaivas; H R Hadley; K M Luber; J L Mostwin; P D O'Donnell; C G Roehrborn
Journal:  J Urol       Date:  1997-09       Impact factor: 7.450

Review 3.  Etiology and management of fecal incontinence.

Authors:  J M Jorge; S D Wexner
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

4.  Prevalence and severity of urinary incontinence and pelvic genital prolapse in females with anal incontinence or rectal prolapse.

Authors:  F X González-Argenté; A Jain; J J Nogueras; G W Davila; E G Weiss; S D Wexner
Journal:  Dis Colon Rectum       Date:  2001-07       Impact factor: 4.585

5.  Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire.

Authors:  G E Lemack; P E Zimmern
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

6.  Measuring the psychosocial impact of urinary incontinence: the York Incontinence Perceptions Scale (YIPS).

Authors:  P S Lee; D W Reid; A Saltmarche; L Linton
Journal:  J Am Geriatr Soc       Date:  1995-11       Impact factor: 5.562

7.  The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasia.

Authors:  D S Ko; H N Fenster; K Chambers; L D Sullivan; M Jens; S L Goldenberg
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

8.  Influence of operations for stress incontinence and/or genital descensus on sexual life.

Authors:  P Haase; L Skibsted
Journal:  Acta Obstet Gynecol Scand       Date:  1988       Impact factor: 3.636

9.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

10.  Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.

Authors:  J S Uebersax; J F Wyman; S A Shumaker; D K McClish; J A Fantl
Journal:  Neurourol Urodyn       Date:  1995       Impact factor: 2.696

View more
  2 in total

1.  Objective Evaluation of Overactive Bladder: Which Surveys Should I Use?

Authors:  Michael Shy; Sophie G Fletcher
Journal:  Curr Bladder Dysfunct Rep       Date:  2013-03-01

2.  Validation of the Spanish-language version of the Prolapse Quality of Life questionnaire in Chilean women.

Authors:  Claudia Flores-Espinoza; Alejandra Ximena Araya; Javier Pizarro-Berdichevsky; Vera Santos; Montserrat Ferrer; Olatz Garin; Steven Swift; Alessandro G Digesu
Journal:  Int Urogynecol J       Date:  2014-09-16       Impact factor: 2.894

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.